Education
About Us
Working with TipRanks
Follow Us
Cryosite Limited (AU:CTE)
:CTE
CTE Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.64 - AU$1.32
Previous CloseN/A
Volume1.46K
Average Volume (3M)1.24K
Market Cap
AU$38.80M
Enterprise ValueAU$58.27M
Total Cash (Recent Filing)AU$4.25M
Total Debt (Recent Filing)AU$0.00
Price to Earnings (P/E)21.2
Beta-0.64
Next Earnings
Aug 22, 2025EPS EstimateN/A
Last Dividend Ex-Date
Sep 06, 2024Dividend Yield8.97%
Share Statistics
EPS (TTM)0.04
Shares Outstanding48,809,563
10 Day Avg. Volume677
30 Day Avg. Volume1,241
Financial Highlights & Ratios
PEG Ratio1.32
Price to Book (P/B)N/A
Price to Sales (P/S)3.14
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Cryosite Limited News
PremiumCompany Announcements
Cryosite Limited Issues Unquoted Equity Securities for Employee Incentive
PremiumCompany Announcements
Cryosite Limited Reports Strong Half-Year FY25 Results and Facility Expansion
PremiumCompany Announcements
Cryosite Limited Unveils New Investor Hub for Enhanced Engagement
PremiumCompany Announcements
Cryosite Limited Announces 2024 Annual General Meeting
PremiumCompany Announcements
Cryosite Limited Shares Company Update
PremiumCompany Announcements
Cryosite Limited Reports Growth and Leadership Changes---
Options Prices
Currently, No data available
---
Ownership Overview
45.16% Insiders
―
Mutual Funds
― Other Institutional Investors
54.84% Public Companies and
Individual Investors
CTE FAQ
What was Cryosite Limited’s price range in the past 12 months?
Cryosite Limited lowest share price was AU$0.64 and its highest was AU$1.32 in the past 12 months.
What is Cryosite Limited’s market cap?
Cryosite Limited’s market cap is AU$38.80M.
When is Cryosite Limited’s upcoming earnings report date?
Cryosite Limited’s upcoming earnings report date is Aug 22, 2025 which is in 145 days.
How were Cryosite Limited’s earnings last quarter?
Cryosite Limited released its earnings results on Feb 20, 2025. The company reported AU$0.017 earnings per share for the quarter, beating the consensus estimate of N/A by AU$0.017.
Is Cryosite Limited overvalued?
According to Wall Street analysts Cryosite Limited’s price is currently Overvalued.
Does Cryosite Limited pay dividends?
Cryosite Limited pays a Annually dividend of AU$0.019 which represents an annual dividend yield of 8.97%. See more information on Cryosite Limited dividends here
What is Cryosite Limited’s EPS estimate?
Cryosite Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cryosite Limited have?
Cryosite Limited has 48,809,563 shares outstanding.
What happened to Cryosite Limited’s price movement after its last earnings report?
Cryosite Limited reported an EPS of AU$0.017 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Cryosite Limited?
Currently, no hedge funds are holding shares in AU:CTE
---
Cryosite Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
18.47%
12-Months-Change
Fundamentals
Return on Equity
87.09%
Trailing 12-Months
Asset Growth
-13.92%
Trailing 12-Months
Company Description
Cryosite Limited
Cryosite Limited offers outsourced clinical trials logistic services in Australia. It operates through two segments, Clinical Trials and Biological Services Logistics, and Cord Blood and Tissues Storage. The Clinical Trials and Biological Services Logistics segment provides specialist temperature-controlled storage, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns management, comparator sourcing, import, export, validated transport, and biological storage solutions to the clinical trials, and research and pharmaceutical industry. The Cord Blood and Tissues Storage segment offers long term storage solutions for cord blood and tissue samples. It serves research, medical, pharmaceutical, veterinary, and biotechnology industries. The company was incorporated in 1999 and is based in South Granville, Australia.
---
Technical Analysis
Ansell
―
CSL
―
Ramsay Health Care
―
Sonic Healthcare Limited
―
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
―
---